Analyst Ranking
Top 18%
#859 out of 4922 analysts
Average Return
+13.63%
Win Rate
48%21 out of 44
Risk vs Reward
Poor
Good

Rachel Vatnsdal's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adaptive Biotechnologies CorpADPT
+177.04%$3.18$8.81
2024-05-08 -
2025-05-07
Strong Buy
Adaptive Biotechnologies CorpADPT
+174.19%$4.30$11.79
2024-08-02 -
2025-06-27
Strong Buy
Adaptive Biotechnologies CorpADPT
+110.35%$3.96$8.33
2024-02-15 -
2025-02-14
Strong Buy
Amyris IncAMRSQ
+97.28%$1.84$0.05
2022-11-10 -
2023-08-18
Strong Sell
Myriad Genetics IncMYGN
+80.29%$26.64$5.25
2024-08-07 -
2025-06-27
Strong Sell

Rachel Vatnsdal's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
10x Genomics IncTXG
4Hold$9.00-23.27%Maintains
2 months ago
Twist Bioscience CorpTWST
2Strong Sell$33.00-8.15%Maintains
2 months ago
Repligen CorpRGEN
6Strong Buy$190.00+53.77%Maintains
2 months ago
Revvity IncRVTY
4Hold$100.00+2.23%Maintains
2 months ago
Envista Holdings CorpNVST
4Hold$19.00-3.41%Maintains
4 months ago
Waters CorpWAT
4Hold$390.00+10.67%Maintains
4 months ago
Tempus Ai IncTEM
3Hold$55.00-17.32%Downgrades
4 months ago
Guardant Health IncGH
1Strong Buy$55.00+8.14%Maintains
4 months ago
Agilent Technologies IncA
6Strong Buy$160.00+34.26%Maintains
7 months ago
Thermo Fisher Scientific IncTMO
8Strong Buy$670.00+64.10%Maintains
9 months ago
Henry Schein IncHSIC
3Strong Buy$80.00+9.19%Maintains
a year ago
Myriad Genetics IncMYGN
3Strong Sell$20.00+280.95%Maintains
a year ago
Mettler Toledo International IncMTD
2Hold$1,400.00+18.19%Maintains
a year ago
Adaptive Biotechnologies CorpADPT
4Strong Buy$6.00-49.11%Maintains
a year ago
Akoya Biosciences IncAKYA
1Strong Buy$10.00N/AMaintains
a year ago
Bruker CorpBRKR
2Strong Buy$90.00N/AUpgrades
a year ago
Danaher CorpDHR
4Strong Buy$270.00N/AMaintains
2 years ago
Catalent IncCTLT
1Hold$45.00N/ADowngrades
2 years ago
Amyris IncAMRSQ
2Strong SellN/AN/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.